Curcumin

Generic Name
Curcumin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C21H20O6
CAS Number
458-37-7
Unique Ingredient Identifier
IT942ZTH98
Background

Curcumin, also known as diferuloylmethane, is an active component in the golden spice turmeric (Curcuma longa) and in Curcuma xanthorrhiza oil. It is a highly pleiotropic molecule that exhibits antibacterial, anti-inflammatory, hypoglycemic, antioxidant, wound-healing, and antimicrobial activities . Due to these properties, curcumin has been investigated for...

Indication

No approved therapeutic indications.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Curcumin; Rose Bengal; Denture Stomatitis

First Posted Date
2021-04-08
Last Posted Date
2021-04-08
Lead Sponsor
King Saud University
Target Recruit Count
45
Registration Number
NCT04837664
Locations
🇸🇦

King Saud University, Riyadh, Saudi Arabia

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

First Posted Date
2021-01-19
Last Posted Date
2023-05-23
Lead Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Target Recruit Count
40
Registration Number
NCT04713631
Locations
🇮🇳

Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India

Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid

Early Phase 1
Completed
Conditions
Bioavailability of Phytonutrients
Interventions
Drug: Curcumin
Drug: Ursolic Acid
First Posted Date
2020-06-09
Last Posted Date
2021-05-05
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
18
Registration Number
NCT04421716
Locations
🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

Early Phase 1
Withdrawn
Conditions
Prostate Cancer
Interventions
Drug: Ursolic Acid
Drug: Curcumin
First Posted Date
2020-05-27
Last Posted Date
2021-09-16
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT04403568
Locations
🇺🇸

Mays Cancer Center, San Antonio, Texas, United States

Evaluating Effects of Curcumin in Moderate to Severe Asthmatics

Phase 2
Withdrawn
Conditions
Asthma
Interventions
Other: Placebo
Drug: Curcumin
First Posted Date
2020-04-20
Last Posted Date
2021-11-17
Lead Sponsor
Loma Linda University
Registration Number
NCT04353310

Curcumin in Advanced Cervical Cancer

First Posted Date
2020-03-04
Last Posted Date
2022-12-07
Lead Sponsor
Instituto Nacional de Cancerologia, Columbia
Registration Number
NCT04294836

Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

First Posted Date
2019-12-20
Last Posted Date
2024-07-03
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
58
Registration Number
NCT04205929
Locations
🇺🇸

OHSU, Portland, Oregon, United States

Curcumin and Exercise in Chronic Kidney Disease

First Posted Date
2019-10-21
Last Posted Date
2023-02-21
Lead Sponsor
University of Iowa
Registration Number
NCT04132648

A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

Phase 1
Active, not recruiting
Conditions
Breast Cancer
Interventions
Drug: Curcumin
First Posted Date
2019-06-10
Last Posted Date
2024-06-25
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
22
Registration Number
NCT03980509
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes

Phase 4
Conditions
PreDiabetes
Interventions
Drug: Starch
Drug: Curcumin
First Posted Date
2019-04-17
Last Posted Date
2019-04-17
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
142
Registration Number
NCT03917784
Locations
🇲🇽

Hospital General de México Dr. Eduardo Liceaga, Mexico City, Cuauhtémoc, Mexico

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy